Clinical Trial Results:
A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the
Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With
Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer
Summary
|
|
EudraCT number |
2008-000422-39 |
Trial protocol |
SE NL ES FI DK GB BE DE IT |
Global completion date |
08 Jun 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 May 2016
|
First version publication date |
20 May 2016
|
Other versions |
|
Summary report(s) |
redacted synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.